Education
About Us
Working with TipRanks
Follow Us
Emyria Ltd (AU:EMD)
ASX:EMD
EMD Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$0.02 - AU$0.06
Previous CloseN/A
Volume148.47K
Average Volume (3M)4.33M
Market Cap
AU$33.21M
Enterprise ValueAU$9.98M
Total Cash (Recent Filing)AU$1.55M
Total Debt (Recent Filing)AU$802.68K
Price to Earnings (P/E)―
Beta0.34
Next Earnings
Feb 26, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding664,160,800
10 Day Avg. Volume3,057,225
30 Day Avg. Volume4,329,350
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
Emyria Ltd News
EMD FAQ
What was Emyria Ltd’s price range in the past 12 months?
Emyria Ltd lowest share price was AU$0.02 and its highest was AU$0.06 in the past 12 months.
What is Emyria Ltd’s market cap?
Emyria Ltd’s market cap is AU$33.21M.
When is Emyria Ltd’s upcoming earnings report date?
Emyria Ltd’s upcoming earnings report date is Feb 26, 2026 which is in 157 days.
How were Emyria Ltd’s earnings last quarter?
Emyria Ltd released its earnings results on Aug 27, 2025. The company reported -AU$0.005 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.005.
Is Emyria Ltd overvalued?
According to Wall Street analysts Emyria Ltd’s price is currently Overvalued.
Does Emyria Ltd pay dividends?
Emyria Ltd does not currently pay dividends.
What is Emyria Ltd’s EPS estimate?
Emyria Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Emyria Ltd have?
Emyria Ltd has 664,160,800 shares outstanding.
What happened to Emyria Ltd’s price movement after its last earnings report?
Emyria Ltd reported an EPS of -AU$0.005 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Emyria Ltd?
Currently, no hedge funds are holding shares in AU:EMD
Emyria Ltd Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
― (―)
― (―)
Blogger Sentiment
Bullish
AU:EMD Sentiment 100%
Sector Average 72%
Sector Average 72%
Insider Transactions
Bought Shares
Worth AU$187.0K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
31.57%
12-Months-Change
Fundamentals
Return on Equity
-81.30%
Trailing 12-Months
Asset Growth
21.99%
Trailing 12-Months
Company Description
Emyria Ltd
Emyria Ltd (EMD) is a clinical-stage biotech company focused on developing innovative treatments and technologies to address unmet needs in the healthcare sector. Specializing in cannabinoid-based medicines and digital health solutions, Emyria leverages its advanced data insights platform to enhance patient care and drive clinical outcomes. The company operates at the intersection of biotechnology and digital health, aiming to deliver novel therapeutic solutions and improve healthcare delivery.
Technical Analysis
Resonance Health Ltd
―
MedAdvisor Limited
―
Singular Health Group Ltd
―
ImExHS Limited
―
PainChek Ltd
―
Options Prices
Currently, No data available
---